{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:13:13Z","timestamp":1790982793475,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11914-020-00574-7","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T05:02:55Z","timestamp":1585371775000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective"],"prefix":"10.1007","volume":"18","author":[{"given":"Lars","family":"Rejnmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Ejlsmark-Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,28]]},"reference":[{"key":"574_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1056\/NEJM199507273330407","volume":"333","author":"EM Brown","year":"1995","unstructured":"Brown EM, Pollak M, Seidman CE, Seidman JG, Chou Y-HW, Riccardi D, et al. Calcium-ion\u2013sensing cell-surface receptors. N Engl J Med. 1995;333:234\u201340. https:\/\/doi.org\/10.1056\/NEJM199507273330407.","journal-title":"N Engl J Med"},{"issue":"1","key":"574_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10408360590886606","volume":"42","author":"Jacob Tfelt-Hansen","year":"2005","unstructured":"Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit. Rev. Clin. Lab. Sci. 2005:35\u201370. https:\/\/doi.org\/10.1080\/10408360590886606.","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"574_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/J.BEEM.2018.06.005","volume":"32","author":"J Bollerslev","year":"2018","unstructured":"Bollerslev J, Pretorius M, Heck A. Parathyroid hormone independent hypercalcemia in adults. Best Pract Res Clin Endocrinol Metab. 2018;32:621\u201338. https:\/\/doi.org\/10.1016\/J.BEEM.2018.06.005.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"574_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.beem.2018.06.005","volume":"32","author":"Jens Bollerslev","year":"2018","unstructured":"Bollerslev J, Pretorius M, Heck A. Parathyroid hormone independent hypercalcemia in adults. Best Pract. Res. Clin. Endocrinol. Metab. 2018. p. 621\u201338.","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"574_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13181-016-0543-y","volume":"12","author":"LK Laskowski","year":"2016","unstructured":"Laskowski LK, Goldfarb DS, Howland MA, Kavcsak K, Lugassy DM, Smith SW. A RANKL wrinkle: denosumab-induced hypocalcemia. J Med Toxicol. 2016;12:305\u20138. https:\/\/doi.org\/10.1007\/s13181-016-0543-y.","journal-title":"J Med Toxicol"},{"key":"574_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/J.BEEM.2018.09.009","volume":"32","author":"NE Cusano","year":"2018","unstructured":"\u2022\u2022 Cusano NE, Cipriani C, Bilezikian JP. Management of normocalcemic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32:837\u201345. https:\/\/doi.org\/10.1016\/J.BEEM.2018.09.009. This paper reports on the diagnosis, clinical features, and management of normocalcemic primary hyperparathyroidism.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"574_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","volume":"1","author":"F Xu","year":"2013","unstructured":"Xu F, Teitelbaum SL. Osteoclasts: new insights. Bone Res. 2013;1:11\u201326. https:\/\/doi.org\/10.4248\/BR201301003.","journal-title":"Bone Res"},{"key":"574_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1302\/2046-3758.61.BJR-2016-0085.R1","volume":"6","author":"L Osagie-Clouard","year":"2017","unstructured":"Osagie-Clouard L, Sanghani A, Coathup M, Briggs T, Bostrom M, Blunn G. Parathyroid hormone 1-34 and skeletal anabolic action. Bone Joint Res. 2017;6:14\u201321. https:\/\/doi.org\/10.1302\/2046-3758.61.BJR-2016-0085.R1.","journal-title":"Bone Joint Res"},{"key":"574_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ecl.2018.07.003","volume":"47","author":"D Goltzman","year":"2018","unstructured":"Goltzman D. Physiology of parathyroid hormone. Endocrinol Metab Clin North Am . Elsevier Inc. 2018;47:743\u201358. https:\/\/doi.org\/10.1016\/j.ecl.2018.07.003.","journal-title":"Endocrinol Metab Clin North Am . Elsevier Inc"},{"key":"574_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/jcem.82.1.3683","volume":"82","author":"GE-H Fuleihan","year":"1997","unstructured":"Fuleihan GE-H, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA. The parathyroid hormone circadian rhythm is truly endogenous\u2014a general clinical research center study. J Clin Endocrinol Metab. 1997;82:281\u20136. https:\/\/doi.org\/10.1210\/jcem.82.1.3683.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/eje.0.1460635","volume":"146","author":"L Rejnmark","year":"2002","unstructured":"Rejnmark L, Lauridsen AL, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. Eur J Endocrinol. 2002;146:635\u201342 https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/146\/5\/635.xml.","journal-title":"Eur J Endocrinol"},{"key":"574_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1359\/jbmr.1997.12.4.616","volume":"12","author":"MH Samuels","year":"1997","unstructured":"Samuels MH, Veldhuis JD, Kramer P, Urban RJ, Bauer R, Mundy GR. Episodic secretion of parathyroid hormone in postmenopausal women: assessment by deconvolution analysis and approximate entropy. J Bone Miner Res. 1997;12:616\u201323. https:\/\/doi.org\/10.1359\/jbmr.1997.12.4.616.","journal-title":"J Bone Miner Res"},{"key":"574_CR13","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/boneres.2014.49","volume":"3","author":"S Chiavistelli","year":"2015","unstructured":"Chiavistelli S, Giustina A, Mazziotti G. Parathyroid hormone pulsatility: physiological and clinical aspects. Bone Res. 2015;3:14049 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26273533.","journal-title":"Bone Res"},{"key":"574_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","volume":"69","author":"L Mosekilde","year":"2008","unstructured":"Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin Endocrinol. 2008;69:1\u201319. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03162.x.","journal-title":"Clin Endocrinol"},{"key":"574_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"Thakker RV. Genetics of parathyroid tumours. J Intern Med. 2016;280:574\u201383. https:\/\/doi.org\/10.1111\/joim.12523.","journal-title":"J Intern Med"},{"key":"574_CR16","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1210\/jc.85.12.4789","volume":"85","author":"F Cetani","year":"2000","unstructured":"Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, et al. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca2+ set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85:4789\u201394. https:\/\/doi.org\/10.1210\/jc.85.12.4789.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR17","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1210\/jc.81.10.3487","volume":"81","author":"CY Guo","year":"1996","unstructured":"Guo CY, Thomas WEG, Al-Dehaimi AW, Assiri AMA, Eastell R. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:3487\u201391. https:\/\/doi.org\/10.1210\/jc.81.10.3487.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"574_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"Shonni J. Silverberg","year":"2009","unstructured":"Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res . 1989;4:283\u2013291. https:\/\/doi.org\/10.1002\/jbmr.5650040302","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"574_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/8756-3282(86)90020-7","volume":"7","author":"E.F. Eriksen","year":"1986","unstructured":"Eriksen EF, Mosekilde L, Melsen F. Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone . 1986;7:213\u2013221. https:\/\/doi.org\/10.1016\/8756-3282(86)90020-7.","journal-title":"Bone"},{"issue":"1","key":"574_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","volume":"41","author":"D.W. Dempster","year":"2007","unstructured":"Dempster DW, M\u00fcller R, Zhou H, Kohler T, Shane E, Parisien M, et al. Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone . 2007;41:19\u201324. https:\/\/doi.org\/10.1016\/j.bone.2007.03.020.","journal-title":"Bone"},{"key":"574_CR21","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1210\/jcem.84.5.5652","volume":"84","author":"DW Dempster","year":"1999","unstructured":"Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, et al. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:1562\u20136. https:\/\/doi.org\/10.1210\/jcem.84.5.5652.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","volume":"321","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Mollerup CL, Fr\u00f8kj\u00e6r VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. Br Med J. 2000;321:598\u2013602. https:\/\/doi.org\/10.1136\/bmj.321.7261.598.","journal-title":"Br Med J"},{"key":"574_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/eje.1.02225","volume":"155","author":"S De Geronimo","year":"2006","unstructured":"De Geronimo S, Romagnoli E, Diacinti D, D\u2019Erasmo E, Minisola S. The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol. 2006;155:415\u201320. https:\/\/doi.org\/10.1530\/eje.1.02225.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"574_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"Marcella D. Walker","year":"2017","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol . 2018;14:115\u2013125. https:\/\/doi.org\/10.1038\/nrendo.2017.104.","journal-title":"Nature Reviews Endocrinology"},{"key":"574_CR25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/jbmr.3461","volume":"33","author":"H Ejlsmark-Svensson","year":"2018","unstructured":"\u2022\u2022 Ejlsmark-Svensson H, Bislev LS, Lajlev S, Harsl\u00f8f T, Rolighed L, Sikjaer T, et al. Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study. J Bone Miner Res. 2018;33:1657\u201364. https:\/\/doi.org\/10.1002\/jbmr.3461. This paper reports a higher BMD in PHPT patients with vertebral fractures compared to patients with osteoporosis and vertebral fractures suggesting that the biomechanical properties of bone in PHPT differs from osteoporosis.","journal-title":"J Bone Miner Res"},{"key":"574_CR26","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1002\/jbmr.5650061417","volume":"6","author":"M Peacock","year":"2009","unstructured":"Peacock M. Interpretation of bone mass determinations as they relate to fracture: implications for asymptomatic primary hyperparathyroidism. J Bone Miner Res. 2009;6:S77\u201382. https:\/\/doi.org\/10.1002\/jbmr.5650061417.","journal-title":"J Bone Miner Res"},{"key":"574_CR27","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 2009;94:2306\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1530\/eje.1.01985","volume":"153","author":"H Kaji","year":"2005","unstructured":"Kaji H, Yamauchi M, Chihara K, Sugimoto T. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism. Eur J Endocrinol. 2005;153:373\u20138. https:\/\/doi.org\/10.1530\/eje.1.01985.","journal-title":"Eur J Endocrinol"},{"key":"574_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jbmr.1841","volume":"28","author":"EM Stein","year":"2013","unstructured":"Stein EM, Silva BC, Boutroy S, Zhou B, Wang J, Udesky J, et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res. 2013;28:1029\u201340. https:\/\/doi.org\/10.1002\/jbmr.1841.","journal-title":"J Bone Miner Res"},{"key":"574_CR30","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/jbmr.98","volume":"25","author":"S Hansen","year":"2010","unstructured":"Hansen S, Beck Jensen J-E, Rasmussen L, Hauge EM, Brixen K. Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J Bone Miner Res. 2010;25:1941\u20137. https:\/\/doi.org\/10.1002\/jbmr.98.","journal-title":"J Bone Miner Res"},{"key":"574_CR31","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen S, Hauge EM, Rasmussen L, Jensen J-EEB, Brixen K. Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res. 2012;27:1150\u20138. https:\/\/doi.org\/10.1002\/jbmr.1540.","journal-title":"J Bone Miner Res"},{"key":"574_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-13-0305","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, et al. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol. 2013;169:155\u201362. https:\/\/doi.org\/10.1530\/EJE-13-0305.","journal-title":"Eur J Endocrinol"},{"key":"574_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12020-019-02099-1","volume":"66","author":"M Liu","year":"2019","unstructured":"Liu M, Williams J, Kuo J, Lee JA, Silverberg SJ, Walker MD. Risk factors for vertebral fracture in primary hyperparathyroidism. Endocrine. 2019;66:682\u201390. https:\/\/doi.org\/10.1007\/s12020-019-02099-1.","journal-title":"Endocrine"},{"key":"574_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jocd.2018.06.005","volume":"22","author":"M Mu\u00f1oz-Torres","year":"2019","unstructured":"Mu\u00f1oz-Torres M, Manzanares C\u00f3rdova R, Garc\u00eda-Mart\u00edn A, Avil\u00e9s-P\u00e9rez MD, Nieto Serrano R, And\u00fajar-Vera F, et al. Usefulness of trabecular bone score (TBS) to identify bone fragility in patients with primary hyperparathyroidism. J Clin Densitom. 2019;22:162\u201370. https:\/\/doi.org\/10.1016\/j.jocd.2018.06.005.","journal-title":"J Clin Densitom"},{"key":"574_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bonr.2018.08.001","volume":"9","author":"JS Leere","year":"2018","unstructured":"Leere JS, Kruse C, Robaczyk M, Karmisholt J, Vestergaard P. Associations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: a retrospective cohort study. Bone Reports. 2018;9:101\u20139 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352187218300470?via%3Dihub.","journal-title":"Bone Reports"},{"key":"574_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4183\/aeb.2018.208","volume":"14","author":"D Grigorie","year":"2018","unstructured":"Grigorie D, Coles D, Sucaliuc A. Trabecular bone score (TBS) has a poor discriminative power for vertebral fractures in 153 Romanian patients with primary hyperparathyroidism. Acta Endocrinol. 2018;14:208\u201312. https:\/\/doi.org\/10.4183\/aeb.2018.208.","journal-title":"Acta Endocrinol"},{"issue":"11","key":"574_CR37","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1001\/archinte.1992.00400230081014","volume":"152","author":"L. Joseph Melton","year":"1992","unstructured":"Melton LJ, Atkinson EJ, O\u2019fallon WM, Heath H. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med . 1992;152:2269\u20132273. https:\/\/doi.org\/10.1001\/archinte.1992.00400230081014.","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"574_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0039-6060(05)80017-0","volume":"118","author":"A KENNY","year":"1995","unstructured":"Kenny AM, MacGillivray DC, Pilbeam CC, Crombie HD, Raisz LG. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery . 1995;118:109\u2013114. https:\/\/doi.org\/10.1016\/S0039-6060(05)80017-0.","journal-title":"Surgery"},{"issue":"3","key":"574_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/17453678909149275","volume":"60","author":"Karin Larsson","year":"1989","unstructured":"Larsson K, Lindh E, Lind L, Persson I, Ljunghall S. Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism. Acta Orthop . 1989;60:268\u2013270. https:\/\/doi.org\/10.3109\/17453678909149275.","journal-title":"Acta Orthopaedica Scandinavica"},{"issue":"10","key":"574_CR40","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"Sundeep Khosla","year":"1999","unstructured":"Khosla S, Melton LJ, Wermers RA, Crowson CS, O\u2019Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res . 1999;14:1700\u20131707. https:\/\/doi.org\/10.1359\/jbmr.1999.14.10.1700.","journal-title":"Journal of Bone and Mineral Research"},{"key":"574_CR41","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1001\/archinte.1987.00370110079012","volume":"147","author":"G Kochersberger","year":"1987","unstructured":"Kochersberger G, Buckley NJ, Leight GS, Martinez S, Studenski S, Vogler J, et al. What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med. 1987;147:1951\u20133. https:\/\/doi.org\/10.1001\/archinte.1987.00370110079012.","journal-title":"Arch Intern Med"},{"issue":"4","key":"574_CR42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1210\/jc.2014-3708","volume":"100","author":"Cristiana Cipriani","year":"2015","unstructured":"Cipriani C, Biamonte F, Costa AG, Zhang C, Biondi P, Diacinti D, et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab . 2015;100:1309\u20131315. https:\/\/doi.org\/10.1210\/jc.2014-3708.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"574_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00423-012-1026-5","volume":"398","author":"L Rolighed","year":"2013","unstructured":"Rolighed L, Vestergaard P, Heickendorff L, Sikjaer T, Rejnmark L, Mosekilde L, et al. BMD improvements after operation for primary hyperparathyroidism. Langenbeck\u2019s Arch Surg. 2013;398:113\u201320. https:\/\/doi.org\/10.1007\/s00423-012-1026-5.","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"574_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-0043-125334","volume":"50","author":"L Zhang","year":"2018","unstructured":"\u2022\u2022 Zhang L, Liu X, Li H. Long-Term skeletal outcomes of primary hyperparathyroidism patients after treatment with parathyroidectomy: a systematic review and meta-analysis. Horm Metab Res. 2018;50:242\u20139. https:\/\/doi.org\/10.1055\/s-0043-125334. A systematic review and meta-analysis reporting on skeletal effects of parathyroidectomy in PHPT.","journal-title":"Horm Metab Res"},{"key":"574_CR45","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/jbmr.3177","volume":"32","author":"K Lundstam","year":"2017","unstructured":"Lundstam K, Heck A, Godang K, Mollerup C, Baranowski M, Pernow Y, et al. Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res. 2017;32:1907\u201314. https:\/\/doi.org\/10.1002\/jbmr.3177.","journal-title":"J Bone Miner Res"},{"key":"574_CR46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jc.2014-3441","volume":"100","author":"K Lundstam","year":"2015","unstructured":"\u2022\u2022 Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2015;100:1359\u201367. Results from the so far largest RCT on mild PHPT reporting beneficial skeletal effects of surgery compared with medical observation.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4158\/EP15704.OR","volume":"22","author":"H \u0160iprov\u00e1","year":"2016","unstructured":"\u0160iprov\u00e1 H, Fry\u0161\u00e1k Z, Sou\u010dek M. Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract. 2016;22:294\u2013301. https:\/\/doi.org\/10.4158\/EP15704.OR.","journal-title":"Endocr Pract"},{"key":"574_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","volume":"42","author":"A Garc\u00eda-Mart\u00edn","year":"2012","unstructured":"Garc\u00eda-Mart\u00edn A, Reyes-Garc\u00eda R, Mu\u00f1oz-Torres M. Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women. Endocrine. 2012;42:764\u20136. https:\/\/doi.org\/10.1007\/s12020-012-9694-z.","journal-title":"Endocrine"},{"key":"574_CR49","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92:3001\u20135. https:\/\/doi.org\/10.1210\/jc.2006-2802.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR50","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462\u201370. https:\/\/doi.org\/10.1210\/jc.2007-1215.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR51","doi-asserted-by":"publisher","unstructured":"van der Plas WY, Noltes ME, van Ginhoven TM, Kruijff S. Secondary and tertiary hyperparathyroidism: a narrative review. Scand J Surg . 2019;[Epub ahead of print]. https:\/\/doi.org\/10.1177\/1457496919866015","DOI":"10.1177\/1457496919866015"},{"issue":"10","key":"574_CR52","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S2213-8587(19)30188-3","volume":"7","author":"Cristiana Cipriani","year":"2019","unstructured":"Cipriani C, Bilezikian JP. Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology. Lancet Diabetes Endocrinol . 2019;7:745\u2013747. https:\/\/doi.org\/10.1016\/S2213-8587(19)30188-3.","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"574_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1210\/jc.2012-2499","volume":"98","author":"L Rejnmark","year":"2013","unstructured":"Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study. J Clin Endocrinol Metab. 2013;98:87\u201396. https:\/\/doi.org\/10.1210\/jc.2012-2499.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR54","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","volume":"32","author":"JY Lee","year":"2018","unstructured":"Lee JY, Shoback DM. Familial hypocalciuric hypercalcemia and related disorders. Best Pract Res Clin Endocrinol Metab. 2018;32:609\u201319. https:\/\/doi.org\/10.1016\/j.beem.2018.05.004.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"26","key":"574_CR55","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","volume":"368","author":"M. Andrew Nesbit","year":"2013","unstructured":"Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, et al. Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia. N Engl J Med. 2013;368:2476\u201386. https:\/\/doi.org\/10.1056\/NEJMoa1300253.","journal-title":"New England Journal of Medicine"},{"key":"574_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","volume":"15","author":"FM Hannan","year":"2019","unstructured":"\u2022\u2022 Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol. 2019;15:33\u201351. https:\/\/doi.org\/10.1038\/s41574-018-0115-0. A very comprehensive review reporting the importance of CaSR.","journal-title":"Nat Rev Endocrinol"},{"key":"574_CR57","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","volume":"18","author":"SE Christensen","year":"2011","unstructured":"Christensen SE, Nissen PH, Vestergaard P, Mosekilde L. Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes. 2011;18:359\u201370. https:\/\/doi.org\/10.1097\/MED.0b013e32834c3c7c.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"574_CR58","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1210\/jc.2015-3442","volume":"101","author":"R Vargas-Poussou","year":"2016","unstructured":"Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio J-P, Travers C, Simian C, et al. Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences. J Clin Endocrinol Metab. 2016;101:2185\u201395. https:\/\/doi.org\/10.1210\/jc.2015-3442.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR59","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2265.2009.03557.x","volume":"71","author":"SE Christensen","year":"2009","unstructured":"Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, et al. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin Endocrinol. 2009;71:798\u2013807. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03557.x.","journal-title":"Clin Endocrinol"},{"key":"574_CR60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0025-6196(12)65614-6","volume":"59","author":"WM Law","year":"1984","unstructured":"Law WM, Wahner HW, Heath H. Bone mineral density and skeletal fractures in familial benign hypercalcemia (hypocalciuric hypercalcemia). Mayo Clin Proc. 1984;59:811\u20135 https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0025619612656146?via%3Dihub.","journal-title":"Mayo Clin Proc"},{"key":"574_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00223-014-9877-0","volume":"95","author":"NFB Jakobsen","year":"2014","unstructured":"Jakobsen NFB, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L. Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. 2014;95:141\u201352. https:\/\/doi.org\/10.1007\/s00223-014-9877-0.","journal-title":"Calcif Tissue Int"},{"key":"574_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00223-011-9517-x","volume":"89","author":"T Isaksen","year":"2011","unstructured":"Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L, Mosekilde L. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif Tissue Int. 2011;89:285\u201394. https:\/\/doi.org\/10.1007\/s00223-011-9517-x.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"574_CR63","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1210\/jc.2015-3442","volume":"101","author":"Rosa Vargas-Poussou","year":"2016","unstructured":"\u2022 Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio JP, Travers C, Simian C, et al. Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences. J Clin Endocrinol Metab. 2016;101:2185\u201395. https:\/\/doi.org\/10.1210\/jc.2015-3442. This study provides evidence for differences between FHH type 1 and 3.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"574_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-017-0692-5","volume":"18","author":"HS J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen HS, Winther S, B\u00f8ttcher M, Hauge EM, Rejnmark L, Svensson M, et al. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol. 2017;18:1\u201310. https:\/\/doi.org\/10.1186\/s12882-017-0692-5.","journal-title":"BMC Nephrol"},{"key":"574_CR65","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1916","volume":"28","author":"TL Nickolas","year":"2013","unstructured":"Nickolas TL, Stein EM, Dworakowski E, Nishiyama KK, Komandah-Kosseh M, Zhang CA, et al. Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res. 2013;28:1811\u201320. https:\/\/doi.org\/10.1002\/jbmr.1916.","journal-title":"J Bone Miner Res"},{"key":"574_CR66","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00198-019-05033-3","volume":"30","author":"S Geng","year":"2019","unstructured":"Geng S, Kuang Z, Peissig PL, Page D, Maursetter L, Hansen KE. Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. Osteoporos Int. 2019;30:2019\u201325. https:\/\/doi.org\/10.1007\/s00198-019-05033-3.","journal-title":"Osteoporos Int"},{"issue":"4","key":"574_CR67","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"John Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int . 2005;68:1793\u20131800. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00596.x.","journal-title":"Kidney International"},{"key":"574_CR68","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, et al. Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol. 2015;26:1466\u201375. https:\/\/doi.org\/10.1681\/ASN.2014040414.","journal-title":"J Am Soc Nephrol"},{"key":"574_CR69","doi-asserted-by":"publisher","first-page":"F1313","DOI":"10.1152\/ajprenal.00147.2010","volume":"298","author":"D Goltzman","year":"2010","unstructured":"Goltzman D. Do calcimimetics directly alter bone remodeling? Am J Physiol Physiol. 2010;298:F1313\u20134. https:\/\/doi.org\/10.1152\/ajprenal.00147.2010.","journal-title":"Am J Physiol Physiol"},{"key":"574_CR70","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40620-017-0397-7","volume":"30","author":"Z Massy","year":"2017","unstructured":"Massy Z, Drueke T. Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease. J Nephrol. 2017;30:629\u201334. https:\/\/doi.org\/10.1007\/s40620-017-0397-7.","journal-title":"J Nephrol"},{"key":"574_CR71","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney disease\u2013mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int. 2017;92:26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006.","journal-title":"Kidney Int"},{"key":"574_CR72","first-page":"355","volume":"25","author":"MI El-Desouki","year":"2004","unstructured":"El-Desouki MI, Othman SM, Fouda MA. Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J. 2004;25:355\u20138.","journal-title":"Saudi Med J"},{"key":"574_CR73","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1172\/JCI112253","volume":"76","author":"AM Parfitt","year":"1985","unstructured":"Parfitt AM, Rao DS, Stanciu J, Villanueva AR, Kleerekoper M, Frame B. Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest. 1985;76:2403\u201312. https:\/\/doi.org\/10.1172\/JCI112253.","journal-title":"J Clin Invest"},{"key":"574_CR74","doi-asserted-by":"crossref","unstructured":"Al-Ali H, Fuleihan GEH. Nutritional osteomalacia: substantial clinical improvement and gain in bone density posttherapy. J Clin Densitom. 2000.","DOI":"10.1385\/JCD:3:1:097"},{"key":"574_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000227.pub4","volume-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men","author":"A Avenell","year":"2014","unstructured":"Avenell A, Mak JCS, O\u2019connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. John Wiley and Sons Ltd: Cochrane Database Syst. Rev; 2014. https:\/\/doi.org\/10.1002\/14651858.CD000227.pub4."},{"key":"574_CR76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/joim.12651","volume":"282","author":"IR Reid","year":"2017","unstructured":"Reid IR, Horne AM, Mihov B, Gamble GD, Al-Abuwsi F, Singh M, et al. Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial. J Intern Med. 2017;282:452\u201360. https:\/\/doi.org\/10.1111\/joim.12651.","journal-title":"J Intern Med"},{"key":"574_CR77","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/jbmr.3442","volume":"33","author":"HM Macdonald","year":"2018","unstructured":"Macdonald HM, Reid IR, Gamble GD, Fraser WD, Tang JC, Wood AD. 25-Hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density: secondary analysis of a randomized controlled trial. J Bone Miner Res. 2018;33:1464\u20139. https:\/\/doi.org\/10.1002\/jbmr.3442.","journal-title":"J Bone Miner Res"},{"key":"574_CR78","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477\u2013501. https:\/\/doi.org\/10.1210\/edrv.22.4.0437.","journal-title":"Endocr Rev"},{"key":"574_CR79","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.archger.2007.12.005","volume":"48","author":"M Bj\u00f6rkman","year":"2009","unstructured":"Bj\u00f6rkman M, Sorva A, Tilvis R. Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr. 2009;48:160\u20136. https:\/\/doi.org\/10.1016\/j.archger.2007.12.005.","journal-title":"Arch Gerontol Geriatr"},{"key":"574_CR80","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00198-014-2687-4","volume":"25","author":"A Shibli-Rahhal","year":"2014","unstructured":"Shibli-Rahhal A, Paturi B. Variations in parathyroid hormone concentration in patients with low 25 hydroxyvitamin D. Osteoporos Int. 2014;25:1931\u20136. https:\/\/doi.org\/10.1007\/s00198-014-2687-4.","journal-title":"Osteoporos Int"},{"key":"574_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00774-010-0200-5","volume":"29","author":"R Okazaki","year":"2011","unstructured":"Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M, Inoue D, et al. Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 load in Japanese subjects. J Bone Miner Metab. 2011;29:103\u201310. https:\/\/doi.org\/10.1007\/s00774-010-0200-5.","journal-title":"J Bone Miner Metab"},{"key":"574_CR82","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00198-009-1163-z","volume":"21","author":"CJ Bacon","year":"2010","unstructured":"Bacon CJ, Woo J, Lau EMCC, Lam CWKK, Gamble GD, Reid IR. Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women. Osteoporos Int. 2010;21:1935\u201341. https:\/\/doi.org\/10.1007\/s00198-009-1163-z.","journal-title":"Osteoporos Int"},{"key":"574_CR83","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00198-011-1606-1","volume":"23","author":"MSM Ardawi","year":"2012","unstructured":"Ardawi MSM, Sibiany AM, Bakhsh TM, Qari MH, Maimani AA. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int. 2012;23:675\u201386. https:\/\/doi.org\/10.1007\/s00198-011-1606-1.","journal-title":"Osteoporos Int"},{"key":"574_CR84","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00198-011-1659-1","volume":"23","author":"A Arabi","year":"2012","unstructured":"Arabi A, Baddoura R, El-Rassi R, El-Hajj FG. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int. 2012;23:971\u201380. https:\/\/doi.org\/10.1007\/s00198-011-1659-1.","journal-title":"Osteoporos Int"},{"key":"574_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2265.2008.03186.x","volume":"69","author":"L Rejnmark","year":"2008","unstructured":"Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics. Clin Endocrinol. 2008;69:29\u201335. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03186.x.","journal-title":"Clin Endocrinol"},{"key":"574_CR86","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bone.2004.02.003","volume":"35","author":"O Sahota","year":"2004","unstructured":"Sahota O, Mundey M, San P, Godber I, Lawson N, Hosking D. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004;35:312\u20139 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328204000675?via%3Dihub.","journal-title":"Bone"},{"key":"574_CR87","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1210\/jc.2009-1294","volume":"95","author":"J Aloia","year":"2010","unstructured":"Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, et al. The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab. 2010;95:3216\u201324. https:\/\/doi.org\/10.1210\/jc.2009-1294.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR88","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4158\/EP.12.2.137","volume":"12","author":"JF Aloia","year":"2006","unstructured":"Aloia JF, Feuerman M, Yeh JK. Reference range for serum parathyroid hormone. Endocr Pract . Endocrine Practice. 2006;12:137\u201344. https:\/\/doi.org\/10.4158\/EP.12.2.137.","journal-title":"Endocr Pract . Endocrine Practice"},{"key":"574_CR89","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00223-010-9416-6","volume":"87","author":"AK Amstrup","year":"2010","unstructured":"Amstrup AK, Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Effects of smoking on severity of disease in primary hyperparathyroidism. Calcif Tissue Int. 2010;87:406\u201313. https:\/\/doi.org\/10.1007\/s00223-010-9416-6.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"574_CR90","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00198-011-1776-x","volume":"23","author":"J. M. Paik","year":"2011","unstructured":"Paik JM, Farwell WR, Taylor EN. Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey . Osteoporos. Int. Springer London; 2012. p. 1727\u20131736. https:\/\/doi.org\/10.1007\/s00198-011-1776-x, 23.","journal-title":"Osteoporosis International"},{"issue":"6848","key":"574_CR91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/bmj.305.6848.273","volume":"305","author":"K. T. Khaw","year":"1992","unstructured":"Khaw KT, Sneyd MJ, Compston J. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. Br Med J. 1992. https:\/\/doi.org\/10.1136\/bmj.305.6848.273.","journal-title":"BMJ"},{"key":"574_CR92","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF02672505","volume":"8","author":"D Collins","year":"1998","unstructured":"Collins D, Jasani C, Fogelman I, Swaminathan R. Vitamin D and bone mineral density. Osteoporos Int. 1998;8:110\u20134. https:\/\/doi.org\/10.1007\/BF02672505.","journal-title":"Osteoporos Int"},{"key":"574_CR93","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00198-016-3692-6","volume":"28","author":"C Gao","year":"2017","unstructured":"Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, et al. The levels of bone turnover markers 25(OH) D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China. Osteoporos Int. 2017;28:211\u20138. https:\/\/doi.org\/10.1007\/s00198-016-3692-6.","journal-title":"Osteoporos Int"},{"key":"574_CR94","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1507\/endocrj.EJ14-0287","volume":"61","author":"SKSH Kim","year":"2014","unstructured":"Kim SKSH, Kim TH, Kim SKSH. Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea national health and nutrition examination survey 2008-2010. Endocr J. 2014;61:1197\u2013204. https:\/\/doi.org\/10.1507\/endocrj.EJ14-0287.","journal-title":"Endocr J"},{"key":"574_CR95","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/cen.12569","volume":"82","author":"C Berger","year":"2015","unstructured":"Berger C, Almohareb O, Langsetmo L, Hanley DA, Kovacs CS, Josse RG, et al. Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol. 2015;82:359\u201368. https:\/\/doi.org\/10.1111\/cen.12569.","journal-title":"Clin Endocrinol"},{"key":"574_CR96","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11657-015-0245-0","volume":"11","author":"R Sayed-Hassan","year":"2016","unstructured":"Sayed-Hassan R, Abazid N, Koudsi A, Alourfi Z. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults. Arch Osteoporos. 2016;11:18. https:\/\/doi.org\/10.1007\/s11657-015-0245-0.","journal-title":"Arch Osteoporos"},{"key":"574_CR97","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00198-018-4602-x","volume":"29","author":"LL R\u00f8dbro","year":"2018","unstructured":"R\u00f8dbro LL, Bislev LS, Sikj\u00e6r T, Rejnmark L. Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels. Osteoporos Int. 2018;29:2211\u20138. https:\/\/doi.org\/10.1007\/s00198-018-4602-x.","journal-title":"Osteoporos Int"},{"key":"574_CR98","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1210\/jc.2013-2198","volume":"98","author":"A Fujiyoshi","year":"2013","unstructured":"Fujiyoshi A, Polgreen LE, Hurley DL, Gross MD, Sidney S, Jacobs DR. A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study. J Clin Endocrinol Metab. 2013;98:4038\u201346. https:\/\/doi.org\/10.1210\/jc.2013-2198.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"574_CR99","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bone.2006.01.140","volume":"39","author":"Asma Arabi","year":"2006","unstructured":"\u2022\u2022 Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect? Bone. 39:268\u201375. https:\/\/doi.org\/10.1016\/j.bone.2006.01.140. A cohort study reporting that serum PTH is more important to bone loss rates in the elderly than 25(OH) D levels.","journal-title":"Bone"},{"key":"574_CR100","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/gerona\/59.12.1285","volume":"59","author":"H Blain","year":"2004","unstructured":"Blain H, Vuillemin A, Blain A, Guillemin F, De Talance N, Doucet BJC. Age-related femoral bone loss in men: evidence for hyperparathyroidism and insulin-like growth factor-1 deficiency. J Gerontol. 2004;59:1285\u20139. https:\/\/doi.org\/10.1093\/gerona\/59.12.1285.","journal-title":"J Gerontol"},{"key":"574_CR101","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1210\/jc.2012-3931","volume":"98","author":"JLJL Hern\u00e1ndez","year":"2013","unstructured":"Hern\u00e1ndez JLJL, Olmos JMJM, Pariente E, Nan D, Mart\u00ednez J, Llorca J, et al. Influence of vitamin D status on vertebral fractures, bone mineral density, and bone turnover markers in normocalcemic postmenopausal women with high parathyroid hormone levels. J Clin Endocrinol Metab. 2013;98:1711\u20137. https:\/\/doi.org\/10.1210\/jc.2012-3931.","journal-title":"J Clin Endocrinol Metab"},{"key":"574_CR102","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4158\/EP-2017-0164","volume":"24","author":"X-F Wang","year":"2018","unstructured":"Wang X-F, Yu J-J, Wang X-J, Jing Y-X, Sun L-H, Tao B, et al. The associations between hypovitaminosis d, higher PTH levels with bone mineral densities, and risk of the 10-year probability of major osteoporotic fractures in Chinese patients with T2DM. Endocr Pract. 2018;24:334\u201341. https:\/\/doi.org\/10.4158\/EP-2017-0164.","journal-title":"Endocr Pract"},{"issue":"3","key":"574_CR103","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00223-010-9454-0","volume":"88","author":"Lars Rejnmark","year":"2010","unstructured":"Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study. Calcif Tissue Int . 2011;88:238\u2013245. https:\/\/doi.org\/10.1007\/s00223-010-9454-0.","journal-title":"Calcified Tissue International"},{"key":"574_CR104","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bone.2006.09.026","volume":"40","author":"P Garnero","year":"2007","unstructured":"Garnero P, Munoz F, Sornay-Rendu E, Delmas PD. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study Bone. 2007;40:716\u201322 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328206007411?via%3Dihub.","journal-title":"The OFELY study Bone"},{"key":"574_CR105","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1359\/jbmr.1998.13.7.1167","volume":"13","author":"K Stone","year":"1998","unstructured":"Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR. Hormonal predictors of bone loss in elderly women: a prospective study. J Bone Miner Res. 1998;13:1167\u201374. https:\/\/doi.org\/10.1359\/jbmr.1998.13.7.1167.","journal-title":"J Bone Miner Res"},{"key":"574_CR106","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s001980050244","volume":"10","author":"E Dennison","year":"1999","unstructured":"Dennison E, Eastell R, Fall CHDD, Kellingray S, Wood PJ, Cooper C. Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporos Int. 1999;10:384\u201391. https:\/\/doi.org\/10.1007\/s001980050244.","journal-title":"Osteoporos Int"},{"key":"574_CR107","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1532-5415.2007.01161.x","volume":"55","author":"A Barone","year":"2007","unstructured":"Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, et al. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc. 2007;55:752\u20137. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01161.x.","journal-title":"J Am Geriatr Soc"},{"key":"574_CR108","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-014-9840-0","volume":"94","author":"P Mosali","year":"2014","unstructured":"Mosali P, Bernard L, Wajed J, Mohamed Z, Ewang M, Moore A, et al. Vitamin D status and parathyroid hormone concentrations influence the skeletal response to zoledronate and denosumab. Calcif Tissue Int. 2014;94:553\u20139. https:\/\/doi.org\/10.1007\/s00223-014-9840-0.","journal-title":"Calcif Tissue Int"},{"key":"574_CR109","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2474-13-244","volume":"13","author":"G Kincse","year":"2012","unstructured":"Kincse G, Varga J, Somogyi P, Szodoray P, Sur\u00e1nyi P, Ga\u00e1l J. The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy. BMC Musculoskelet Disord. 2012;13:244. https:\/\/doi.org\/10.1186\/1471-2474-13-244.","journal-title":"BMC Musculoskelet Disord"},{"key":"574_CR110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2474-8-3","volume":"8","author":"A Deane","year":"2007","unstructured":"Deane A, Constancio L, Fogelman I, Hampson G. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet Disord. 2007;8:3. https:\/\/doi.org\/10.1186\/1471-2474-8-3.","journal-title":"BMC Musculoskelet Disord"},{"key":"574_CR111","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00223-018-0481-6","volume":"104","author":"LS Bislev","year":"2019","unstructured":"\u2022\u2022 Bislev LS, Langagergaard R\u00f8dbro L, Rolighed L, Sikjaer T, Rejnmark L. Bone microstructure in response to vitamin D3 supplementation: a randomized placebo-controlled trial. Calcif Tissue Int. 2019;104:160\u201370. https:\/\/doi.org\/10.1007\/s00223-018-0481-6. A RCT on bone effects of decreasing PTH levels by vitamin D supplementation in postmenopausal women.","journal-title":"Calcif Tissue Int"},{"key":"574_CR112","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2014;99:1072\u201380. https:\/\/doi.org\/10.1210\/jc.2013-3978.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00574-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-020-00574-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00574-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:36:54Z","timestamp":1616891814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-020-00574-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s11914-020-00574-7","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,28]]},"assertion":[{"value":"28 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}